Mephentermine--a new circulation-active anti hypotensive drug
Seige, K.; Preuss, E.G.; Schneider, W.; Schwartze, D.; Müller, E.; Mann, D.; Lietz, W.; Wiessner, W.
Das Deutsche Gesundheitswesen 27(1): 1-8
1972
ISSN/ISBN: 0012-0219 PMID: 4552011 Document Number: 45663
Document emailed within 1 workday
Related Documents
Alpermann, H.G.; Ruschig, H.; Meixner, W. 1972: 4-(2-chloro-3-methylphenylamine)-3-thiophene-carboxylate, a highly active anti-inflammatory drug Arzneimittel-Forschung 22(12): 2146-2147Ferrada, P. 2018: Shifting Priorities from Intubation to Circulation first in Hypotensive Trauma Patients American Surgeon 84(2): E75-E76
Furuya, Y.; Ooe, Y.; Tanaka, S.; Nagara, M.; Yamamura, Y.; Fujita, M. 1979: Effects of vasoactive drugs on renal circulation. III. Hypotensive agents Masui. Japanese Journal of Anesthesiology 28(10): 1046-1053
Gmiński, J.; Stajszczyk, M. 1996: Anti-atherosclerotic action of hypotensive drugs Wiadomosci Lekarskie 49(7-12): 182-198
Waeber, B.; Nussberger, J.; Brunner, H.R.; de Agostini, A.; Schapira, M. 1984: Hypotensive effect of human factor XIi active fragment in conscious normotensive rats: role of bradykinin Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 2(3): S341-S342
Amery, A.; Fagard, R.; Fiocchi, R.; Lijnen, P.; Staessen, J.; Vanhees, L. 1985: Ketanserin: a new hypotensive drug? Journal of Cardiovascular Pharmacology 7(Suppl 7): S176-S182
Noordhoek, J.; Bonta, I.L. 1972: The mechanism of the anti-inflammatory and hypotensive effect of carrageenin in rats Archives Internationales de Pharmacodynamie et de Therapie 197(2): 385-386
Gruppillo, P.; Tomaini, M.D. 1982: Clinical study of a new hypotensive drug association La Clinica Terapeutica 103(6): 623-633
Valdman, A.V.; Afanaseva, N.B.; Beshimov, A.; Brovkov, M.F.; Petriaevskaya, N.V.; Tsyrlin, V.A. 1974: Experiments with a new hypotensive drug -- Catapressan (clonidine) Cor et Vasa 16(4): 282-290
Shikary, Z.K.; Betrabet, S.S.; Patel, Z.M.; Patel, S.; Joshi, J.V.; Toddywala, V.S.; Toddywala, S.P.; Patel, D.M.; Jhaveri, K.; Saxena, B.N. 1987: ICMR task force study on hormonal contraception. Transfer of levonorgestrel (LNG) administered through different drug delivery systems from the maternal circulation into the newborn infant's circulation via breast milk Contraception 35(5): 477-486
Spach, M.O.; Imbs, J.L.; Bloch, R.; Schwartz, J. 1971: A major hypotensive drug with central action: catapressan La Presse Medicale 79(3): 101
Parsons, D.; Convertino, V.; Idris, A.; Smith, S.; Lindstrom, D.; Parquette, B.; Aufderheide, T. 2009: The impedance threshold device (ITD-7)--a new device for combat casualty care to augment circulation and blood pressure in hypotensive spontaneously breathing warfighters Journal of Special Operations Medicine: a Peer Reviewed Journal for Sof Medical Professionals 9(2): 49-53
Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Lauckner, W.; Schwarz, R.; Retzke, U. 1978: Suitability of mephentermine for the management of arterial hypotension in pregnancy Zentralblatt für Gynakologie 100(4): 217-221
Nakahara, H.; Nakazawa, M.; Tsukada, T.; Imai, S. 1985: Mechanism of the hypotensive effect of a new beta-adrenergic blocking drug, arotinolol (S-596) in anesthetized rabbits Archives Internationales de Pharmacodynamie et de Therapie 277(2): 253-263
Lü, M.; Wang, T.-y.; Tian, X.-x.; Shi, X.-h.; Fan, G.-w.; Zhang, Y.; Zhu, Y. 2015: Interaction of anti-thrombotic and anti-inflammatory activities of commonly used traditional Chinese medicine for promoting blood circulation and removing blood stasis revealed by network pharmacology analysis Yao Xue Xue Bao 50(9): 1135-1141
Phillips, D.R.; White, R.J.; Trist, H.; Cullinane, C.; Dean, D.; Crothers, D.M. 1990: New insight into drug-DNA interactions at individual drug binding sites probed by RNA polymerase during active transcription of the DNA Anti-Cancer Drug Design 5(1): 21-29
Villarroya, F.; Domingo, P.; Giralt, M. 2005: Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity Trends in Pharmacological Sciences 26(2): 88-93
Huber, O.; Greenberg, M.L.; Huber, J. 1979: Complement-fixing anti--double-stranded DNA with the Crithidia method: a better indicator of active SLE than anti-DNA with the Farr method Journal of Laboratory and Clinical Medicine 93(1): 32-39
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168